(Natural News) Struggling to find clinical benefits for statin drugs and blood pressure medications, a team of researchers put two drug protocols to the test to see their effects on human thinking and memory. The research, funded by the maker of the drugs (AstraZeneca), hoped to find cognitive benefits for candesartan and hydrocholorothiazide, rosuvastatin, or a combination of the protocols. The study was published online in Neurology, the medical journal for the American Academy of Neurology (AAN). The AAN represents the world’s largest association of neurologists and neuroscience professionals and is dedicated to promoting the highest quality patient-centered neurological care.
Alex Pietrowski, Staff Writer Waking Times A physician’s word is often taken very seriously and with little skepticism. An opinion from one or two doctors, when made in a professional office or hospital, can persuade a worried patient to take drugs with complex side-effects, or even undergo traumatic treatments such as radiation and chemotherapy. Yet, when the…..Read more
By The World Mercury Project Team European Union (EU) residents have less confidence in vaccine safety than people in any other region in the world. From the perspective of the powerful pharmaceutical industry and its bought politicians, this growing skepticism about vaccine orthodoxy cannot be permitted to gain further momentum. Ignoring massive protests by citizens…Read more